ArticleJHEP reports : innovation in hepatology2025

Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab.

Simon Johannes Gairing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.